COMP <GO>
MZTI vs FRPT // EV/EBITDA & P/E VALUATION
The Marzetti Company (NASDAQ) VS. Freshpet Inc. (NASDAQ) • 15-METRIC TALLY: MZTI 7
— FRPT 5
▲ EV/EBITDA & P/E VALUATION LEADER: MZTI
LAST: $109.12 (+0.66%) • MKT CAP: $2.98B
valuation
10.3x
LAST: $66.12 (+1.63%) • MKT CAP: $3.18B
valuation
38.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MZTI VS. FRPT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MZTI | FRPT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 23.90% | 40.80% | -16.90 | FRPT | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.90% | 6.40% | +14.50 | MZTI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.3x | 38.3x | -28.00 | MZTI | /valuation <GO> |
| Free Cash Flow Yield | 6.83% | 5.05% | +1.78 | MZTI | /fcf-yield <GO> |
| Operating Margin | 11.50% | 6.90% | +4.60 | MZTI | /operating-margins <GO> |
| Net Profit Margin | 8.80% | 12.60% | -3.80 | FRPT | /net-margins <GO> |
| Revenue Growth (YoY) | 2.00% | 13.00% | -11.00 | FRPT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 3.48% | 0.00% | +3.48 | MZTI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.24 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | FRPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.6 | 58.4 | +3.24 | MZTI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.6x | 19.2x | -2.60 | MZTI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.98B | $3.18B | -$199.6M | FRPT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MZTI REV | FRPT REV | MZTI GROSS % | FRPT GROSS % | MZTI FCF | FRPT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.91B | $1.10B | 23.9% | 40.8% | $203.5M | $160.6M |
| FY 2024 | $1.87B | $975.2M | 23.1% | 40.6% | $184.0M | $154.3M |
| FY 2023 | $1.82B | $766.9M | — | — | $225.9M | $75.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MZTI // BETA —
FRPT // BETA —